BioCentury
ARTICLE | Company News

MGI deal

May 17, 1993 7:00 AM UTC

MGI Pharma Inc. (MOGN) MGI Pharma Inc. (MOGN) has acquired the patent rights to anti-estrogenic cancer agents from Research Corporation Technologies. The tumor growth blockers, which will be studied ...